9 completed, 8 unknown, 3 recruiting, 2 not yet recruiting. 10 Not applicable, 6 Phase 2, 5 Phase 1, 4 Phase 3, 3 Phase 4.
Follow Placebo Control Group: new trials by email Literature Review of Placebo Control Group trials Research Report on Placebo Control Group
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tart Cherry Citrate Effervescent Tablet for Urate-Lowering Therapy in Participants With Asymptomatic Hyperuricemia tart cherry citrate effervescent table, Placebo Control Group - Hyperuricemia With or Without Gout | Not applicable | Recruiting | Beijing Zhecheng Biotechnology Co., Ltd. | 196 | 2026-06-04 | 2026-06-17 |
| EFFECTS OF CİTRUS AND CLOVE OİL AROMATHERAPY İN OLDER ADULTS Intervention Group 1, Intervention Group 2, Placebo Control Group - Aromatherapy | Not applicable | Not yet recruiting | Mersin University | 51 | 2026-02-01 | 2026-01-26 |
| Efficacy and Safety of Functional Neurogenesis Stimulation Therapy in Children With Autism Spectrum Disorder (ASD) Functional Neurogenesis Stimulation Therapy, placebo control group - Autism Spectrum Disorder | Not applicable | Not yet recruiting | Neurocytonix, Inc. | 256 | 2026-02-01 | 2025-12-16 |
| A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation Placebo control group, Human-derived active intestinal bacterial liquid group - Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI) | Phase 2 / Phase 3 | Recruiting | Shanghai University of Traditional Chinese Medicine | 60 | 2025-12-10 | 2026-01-15 |
| ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group - Cognitive Dysfunction, Alzheimer Disease | Phase 2 | Recruiting | Michal Schnaider Beeri, Ph.D. | 20 | 2025-01-12 | 2026-02-06 |
| Y-3 for Injection in the Treatment of Acute Ischemic Stroke Y-3 for injection, Placebo control group - Acute Ischemic Stroke | Phase 3 | Completed | Beijing Tiantan Hospital | 998 | 2024-07-24 | 2026-07-07 |
| Research on PSMA-Targeted Intraoperative Fluorescent Imaging Agents 0.01mg/kg DGPR1008 Injection Dose Group 1 (n=6), 0.02mg/kg DGPR1008 Injection Dose Group 2 (n=6), 0.04mg/kg DGPR1008 Injection Dose Group 3 (n=6) - Prostate Cancer Patients Undergoing Radical Prostatectomy, Prostate CA | Phase 1 | Completed | Haitao Niu, MD | 32 | 2024-06-24 | 2025-08-03 |
| GD-11 for Injection in the Treatment of Acute Ischemic Stroke GD-11 for injection test group, Placebo control group - Acute Ischemic Stroke | Phase 3 | Unknown | Beijing Tiantan Hospital | 980 | 2024-02-29 | 2024-03-15 |
| The Effect of Aromatherapy Massage on Sleep Quality Intervention 1 Group, Intervention 2 Group, Placebo Control Group - Diabetes Mellitus, Respiratory Failure | Not applicable | Unknown | Nilgün Erdoğan | 62 | 2024-01-05 | 2024-03-06 |
| A Pilot Study of Sivelestat Sodium to Shorten Mechanical Ventilation in Acute Aortic Dissection Sivelestat sodium was given intravenously, Placebo was given intravenously - Acute Aortic Dissection | Not applicable | Unknown | Xiaotong Hou | 30 | 2023-05-01 | 2023-05-25 |
| The Use of Isatidis Root and Forsythia Oral Liquid for the Treatment of Mild Cases of COVID-19: A Trial Clinical Study Langenlianqiao, LianhuaQingWen, placebo control group - Treatment of Mild Cases of COVID-19 | Phase 1 | Completed | Central South University | 253 | 2022-11-01 | 2024-04-09 |
| Atorvastatin Effect on Reduction of COPD Exacerbations Atorvastatin 40 Mg Oral Tablet, Placebo - Copd, COPD Exacerbation | Phase 4 | Active not recruiting | Medical University of Bialystok | 460 | 2022-02-11 | 2026-04-21 |
| Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy UC-MSCs, Placebo - Diabetic Nephropathy | Not applicable | Unknown | Renmin Hospital of Wuhan University | 38 | 2020-09-25 | 2020-09-24 |
| A Study of Thienorphine Hydrochloride Tablets in Relapse Prevention Treatment of Opioid Dependence 0.2mg group, 0.5mg group, placebo control group - Opioid Dependence | Phase 2 | Unknown | Wei Hao | 180 | 2018-08-31 | 2018-09-04 |
| Effectiveness of Probiotics Prophylaxis of Urinary Tract Infections in Children Placebo control group, Probiotic experimental group - Prevention of Urinary Tract Infections in Children | Not applicable | Unknown | Medical University of Warsaw | 106 | 2018-04-01 | 2018-03-12 |
| Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients. Autologous Bone marrow mononuclear cells, Placebo control - Acute Myocardial Infarction | Phase 1 / Phase 2 | Unknown | TotipotentRX Cell Therapy Pvt. Ltd. | 30 | 2013-12-01 | 2013-09-04 |
| Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows Track A, Track B - Hypotrichosis | Phase 4 | Completed | ATS Clinical Research | 33 | 2013-05-01 | 2015-01-14 |
| Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting Palonosetron, placebo control group - Laparoscopic Gynecologic, Abdominal, Other Surgery, General Anesthesia | Phase 3 | Completed | Samsung Medical Center | 384 | 2012-01-01 | 2013-12-25 |
| Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke Autologous BMSCs transplantation, Autologous EPCs transplantation, IV infusion of placebo - Stroke, Infarction, Middle Cerebral Artery | Phase 1 / Phase 2 | Completed | Southern Medical University, China | 20 | 2011-11-01 | 2021-04-02 |
| Effects of Exercise Intervention and Rehabilitation Exercise Intervention in Patients With Type 2 Diabetes rehabilitation exercise intervention, placebo control group - Diabetes, Diabetes Mellitus, Non-Insulin-Dependent | Not applicable | Completed | University of Giessen | 68 | 2010-02-01 | 2011-11-08 |
Showing 20 of 24. Sign in to see all of them.
Ischemic Stroke (3) · Diabetes Mellitus (2) · Acute Lung Injury (1) · Alzheimer Disease (1) · Apolipoprotein E, Deficiency or Defect of (1) · Autism Spectrum Disorder (1) · Central Nervous System Diseases (1) · Cerebral Infarction (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Dementia (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Nephropathies (1) · Disease (1) · Headache (1)
Beijing Tiantan Hospital (2) · ATS Clinical Research (1) · Beijing Zhecheng Biotechnology Co., Ltd. (1) · Central South University (1) · Federal University of São Paulo (1) · Haitao Niu, MD (1) · Medical University of Bialystok (1) · Medical University of Warsaw (1) · Mersin University (1) · Michal Schnaider Beeri, Ph.D. (1) · National Institute on Aging (NIA) (1) · Neurocytonix, Inc. (1) · Nilgün Erdoğan (1) · Renmin Hospital of Wuhan University (1) · Samsung Medical Center (1)
China (9) · United States (6) · Poland (2) · Brazil (1) · Germany (1) · India (1) · Mexico (1) · South Korea (1) · Turkey (Türkiye) (1)
Andree Hillebrecht, Dr. med. (1) · Ashok Seth, FRCP, FACC (1) · Ava Shamban, MD (1) · Dusan Hamar, Prof. Dr. (1) · Hanna Szymanik-Grzelak, PhD (1) · Jiska Cohen-Mansfield, PhD (1) · Jose R Trujillo, M.D., Sc.D. (1) · Joun Heum Yeon, MD, PhD (1) · Jung Won Hwang, MD, PhD (1) · Kenneth Harris, MS (1) · Lorenzo R Morales Mancias, M.D. (1) · Malgorzata Panczyk-Tomaszewska, Assistant Professor (1) · Marcelo Darabos, MD (1) · Marcelo F Mello, MD (1)
PMID 11315017, PMID 11673584, PMID 14758172, PMID 16554988, PMID 18410258, PMID 18598362, PMID 18722781, PMID 1884569, PMID 19011770, PMID 19447800, PMID 19480669, PMID 20110753, PMID 20354035, PMID 20376727, PMID 20384750, PMID 20384751, PMID 20576835, PMID 21127322, PMID 21143878, PMID 21766228, PMID 21881324, PMID 22105690, PMID 23059151, PMID 23118932, PMID 23295957, PMID 23596346, PMID 23631417, PMID 23774238, PMID 23834653, PMID 24075485, PMID 24750107, PMID 25037960, PMID 25705413, PMID 26140267, PMID 26695595, PMID 27756811, PMID 28442313, PMID 28792873, PMID 29102297, PMID 29118307, PMID 29707315, PMID 30156755, PMID 32030257, PMID 33097017, PMID 33211886, PMID 33353985, PMID 37679816, PMID 41344725, PMID 42721021
R01AG010172 (1), R21AT003735 (1)